Skip to main content

Additional Costs for Preventing the Spread of Methicillin-Resistant Staphylococcus aureus and a Strategy for Reducing These Costs on a Surgical Ward

  • Caroline Eva Wella Herr (a1), Thomas Hilarius Heckrodt (a1), Frank Andreas Hofmann (a1), Reinhard Schnettler (a2) and Thomas Friedrich Eikmann (a1)...

To determine the added costs of hygienic measures (barrier precautions, isolation, and decontamination) required for MRSA carriers in German hospitals and possible strategies for cost reduction.


On a septic surgical ward caring for 35% of all MRSA cases in a university hospital (1,182 beds), additional costs for personnel time and materials were calculated and medical charts of all MRSA cases admitted to the ward during 1 year were analyzed retrospectively. Twelve of the ward's 13 beds were located in rooms with at least 2 beds.


Four hundred ninety-eight MRSA carrier hospital-days (of 20 MRSA cases) could be assessed. All patients (80% men, 50% older than 74.5 years) had broken skin.


In 95% of the cases, microbiological findings suggested transmission of MRSA during the current or a previous stay on this ward. The study found total avoidable costs of approximately 142,794.01 euros in 1 year, averaging 371.95 euros for one MRSA patient hospital-day and 9,261.56 euros per MRSA case. The most expensive single measure was blocked beds in multibed rooms (305.75 euros/day), which accounted for 82% of the extra costs. Costs most likely were underestimated.


Daily additional case costs amounted to 96% of social security payments. Blocked beds in multibed rooms accounted for more than 80% of these excess costs. Isolation has been scientifically validated and is required by law in Germany. Building an adequate number of single-bed rooms should help prevent spread and would greatly lower the added costs of infection.

Corresponding author
Institute of Hygiene and Environmental Medicine, Justus-Liebig University of Giessen, Friedrichstrasse 16, D-35385 Giessen, Germany
Hide All
1.Farr BM, Jarvis WR. Would active surveillance cultures help control healthcare-related methicillin-resistant Staphylococcus aureus infections? Infect Control Hosp Epidemiol 2002;23:6568.
2.Geldner G, Ruoff M, Hoffmann HJ, Kiefer P, Georgieff M, Wiedeck H. Cost analysis concerning MRSA-infection in ICU [in German]. Anasthesiol Intensivmed Notfallmed Schmerzther 1999;34:409413.
3.Rubin RJ, Harrington CAPoon A, Dietrich K, Greene JAMoiduddin AThe economic impact of Staphylococcus aureus infection in New York City hospitals. Emerg Infect Dis 1999;5:917.
4.Kim X, Oh PI, Simor AE. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals. Infect Control Hosp Epidemiol 2001;22:99104.
5.Papia G, Louie M, Tralla A, Johnson C, Collins V, Simor AE. Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost effective? Infect Control Hosp Epidemiol 1999;20:473477.
6.Chaix C, Durand-Zaleski I, Alberti C, Brun-Buisson C. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA 1999;282:17451751.
7.Karchmer TB, Durbin LJ, Simonton BM, Farr BM. Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2002;51:126132.
8.Empfehlung zur Prävention und Kontrolle von Methicillin-resistent Staphylococcus aureus-Stämmen (MRSA) in Krankenhäusern und anderen medizinischen Einrichtungen: Mitteilung der Kommission für Krankenhaushygiene und Infektionsprävention am RKI. Bundesgesundheitsbl 1999;42:954958.
9.Hospital Infection Control Practices Advisory Committee. Guideline for isolation precautions in hospitals: Part II. Recommendations for isolation precautions in hospitals. Am J Infect Control 1996;24:3252.
10.Gesetz zur Verhütung und Bekämpfung von Infektionskrankheiten beim Menschen Infektionsschutzgesetz: IFSG. Bundesgesetzblatt Jahrgang 2000;33.
11.Domann E, Hossain H, Fussle R, Chakraborty T. Rapid and reliable detection of multiresistant Staphylococcus aureus (MRSA) by multiplex PCR [in German]. Dtsch Med Wochenschr 2000;125:613618.
12.Vandenbroucke-Grauls CM. Methicillin-resistant Staphylococcus aureus control in hospitals: the Dutch experience. Infect Control Hosp Epidemiol 1996;17:512513.
13.Minnesota Department of Health, Infectious Disease Prevention and Control Division, Facility and Provider Compliance Division. Guideline for the Management of Antimicrobial Resistant Microorganisms in Minnesota Long-Term Care Facilities. St. Paul, MN: Minnesota Department of Health; 2000. Available at Accessed August 10, 2003.
14.Rubinovitch B, Pittet DI. Screening for methicillin-resistant Staphylococcus aureus in the endemic hospital: what have we learned? J Hosp Infect 2001;47:918.
15.Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997;10:505520.
16.Andersen BM, Lindemann R, Bergh K, et al.Spread of methicillin-resistant Staphylococcus aureus in a neonatal intensive unit associated with understaf fing, overcrowding and mixing of patients. J Hosp Infect 2002;50:1824.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Infection Control & Hospital Epidemiology
  • ISSN: 0899-823X
  • EISSN: 1559-6834
  • URL: /core/journals/infection-control-and-hospital-epidemiology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Full text views

Total number of HTML views: 0
Total number of PDF views: 3 *
Loading metrics...

Abstract views

Total abstract views: 193 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 23rd January 2018. This data will be updated every 24 hours.